Erin K. Zahradnik, MD

The authors reply to Goldman and Markov’s comments on their recent study of dispensary-obtained THC for dementia.

Neuropsychiatric symptoms (NPS) in dementia are challenging to manage, and available treatments have a significant side effect profile. This study evaluated the effectiveness of dispensary-obtained tetrahydrocannabinol for patients with...